EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pharmaceutical 3D Printing Technology Integrating Nanomaterials and Nanodevices for Precision Neurological Therapies

Jurga Bernatoniene iD, Mindaugas Plieskis, Kestutis Petrikonis

Pharmaceutics · 09.03.2025 · 17 (3) · 352

DOI: 10.3390/pharmaceutics17030352 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 09.03.2025. Verfasst von Jurga Bernatoniene und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Sukileliu pr. 13, …. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Lithuania (LMTLT), Science Foundation of the Lithuanian University of Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmaceutical 3D printing, combined with nanomaterials and nanodevices, presents a transformative approach to precision medicine for treating neurological diseases. This technology enables the creation of tailored dosage forms with controlled release profiles, enhancing drug delivery across the blood−brain barrier (BBB). The integration of nanoparticles, such as poly lactic-co-glycolic acid (PLGA), chitosan, and metallic nanomaterials, into 3D-printed scaffolds improves treatment efficacy by providing targeted and prolonged drug release. Recent advances have demonstrated the potential of these systems in treating conditions like Parkinson’s disease, epilepsy, and brain tumors. Moreover, 3D printing allows for multi-drug combinations and personalized formulations that adapt to individual patient needs. Novel drug delivery approaches, including stimuli-responsive systems, on-demand dosing, and theragnostics, provide new possibilities for the real-time monitoring and treatment of neurological disorders. Despite these innovations, challenges remain in terms of scalability, regulatory approval, and long-term safety. The future perspectives of this technology suggest its potential to revolutionize neurological treatments by offering patient-specific therapies, improved drug penetration, and enhanced treatment outcomes. This review discusses the current state, applications, and transformative potential of 3D printing and nanotechnology in neurological treatment, highlighting the need for further research to overcome the existing challenges.

Schlagwörter

Stichwörter der Autor:innen

3D pharmaceutical printingnanodevicesnanomaterialsneurological diseases

Autor:innen und Institutionen

  • Department of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Sukileliu pr. 13, LT-50161 Kaunas, Lithuania.
  • Institute of Pharmaceutical Technologies, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Sukileliu pr. 13, LT-50161 Kaunas, Lithuania.
  • SwissHealix GmbH, Gutsch 21, Allenwinden, 6319 Zug, Switzerland.
  • Department of Neurology, Lithuanian University of Health Sciences, Eivenių str. 2, LT-50009 Kaunas, Lithuania.

ORCID-Profile: Jurga Bernatoniene

Förderung

  • Research Council of Lithuania (LMTLT)
  • Science Foundation of the Lithuanian University of Health Sciences

Zitieren

APA

Bernatoniene, J., Plieskis, M., & Petrikonis, K. (2025). Pharmaceutical 3D Printing Technology Integrating Nanomaterials and Nanodevices for Precision Neurological Therapies. Pharmaceutics, 17(3), 352. https://doi.org/10.3390/pharmaceutics17030352

Vancouver

Bernatoniene J, Plieskis M, Petrikonis K. Pharmaceutical 3D Printing Technology Integrating Nanomaterials and Nanodevices for Precision Neurological Therapies. Pharmaceutics. 2025;17(3):352. doi:10.3390/pharmaceutics17030352

BibTeX
@article{Bernatoniene2025,
  author = {Bernatoniene, Jurga and Plieskis, Mindaugas and Petrikonis, Kestutis},
  title = {Pharmaceutical 3D Printing Technology Integrating Nanomaterials and Nanodevices for Precision Neurological Therapies},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {352},
  doi = {10.3390/pharmaceutics17030352}
}
Kostenlos starten →